Biotech Delivers a Superior Patient and Site Experience with the Medidata Platform™

Rezolute, a small biotech developing rare-disease treatments, faced patient recruitment and retention challenges in ultra-rare conditions. It implemented Medidata's unified platform -- Rave, eCOA, RTSM, Site Payments, Safety Gateway, and Coder -- run by a five-person clinical team. The page reports faster study startup and regulatory approvals, improved protocol compliance via real-time visibility, better patient experience through automated reminders, and site payments in 30 days versus the industry-standard 90 days, with a single-login system reducing training needs and improving communication across stakeholders.

Medidata is a Dassault Systèmes company supplying the clinical-trial EDC and data platform (Rave) most sponsors and CROs already run live trials on, now with an AI layer built in.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.